Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00–150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 361–375 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-880 HEV Viral Load Quantitative Test This test quantifies the amount of Hepatitis E virus RNA present in a sample, indicating active viral replication.	Blood (serum or plasma) or stool	3 working days (email) / 24 hours (phone notification)	1,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Hepatitis E virus RNA", "Viral Load (IU/mL)"] Parameters [{"name": "HEV RNA Viral Load", "reference_range": "Undetectable (IU/mL)"}] Preparation ["No fasting required", "Bring signed consent form", "Bring prior hepatitis E records if available", "Bring insurance card if applicable"] Indications ["Confirmation of active Hepatitis E infection", "Monitoring viral replication in chronic cases", "Guiding antiviral therapy", "Assessing treatment response"] Measurement technique Confirm with laboratory Codes LOINC: 88217-1 ICD-10: B17.2, B18.2, Z11.59 Clinical summary This test quantifies the amount of Hepatitis E virus RNA present in a sample, indicating active viral replication.
TEST-5825 HEXB Gene Sandhoff Disease Genetic Test This test detects pathogenic variants in the HEXB gene associated with Sandhoff disease using Next Generation Sequencing.	Peripheral Whole Blood (3–5 mL) or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in HEXB gene", "Single nucleotide variants", "Small insertions/deletions"] Parameters [] Preparation ["Pre-test genetic counseling and signed informed consent are mandatory"] Indications ["Suspected Sandhoff disease", "Confirmed family history of Sandhoff disease", "Genetic counseling", "Family planning decisions"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: E75.01 Clinical summary This test detects pathogenic variants in the HEXB gene associated with Sandhoff disease using Next Generation Sequencing.
TEST-5977 HGD Gene Alkaptonuria Genetic Test This genetic test identifies mutations in the HGD gene associated with Alkaptonuria.	Whole Blood / FTA Card / Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the HGD gene", "Homogentisate 1,2-dioxygenase gene sequence"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any recent blood transfusions"] Indications ["Clinical suspicion of Alkaptonuria", "Carrier screening in consanguineous families", "Pre-marital genetic counselling", "Family history of Alkaptonuria"] Measurement technique Confirm with laboratory Codes LOINC: 90562-2 ICD-10: E70.29 Clinical summary This genetic test identifies mutations in the HGD gene associated with Alkaptonuria.
TEST-845 HHV-6 DNA and RNA Qualitative Detection Test This test detects the presence of Human Herpesvirus 6 (HHV-6) DNA and RNA in various body fluids.	Saliva, Whole Blood, Cerebrospinal Fluid (CSF), Lymph Node Tissue, Biopsy Samples	24–36 hours (preliminary RNA result at 24 h)	650.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["HHV-6 DNA", "HHV-6 RNA"] Parameters [] Preparation [] Indications ["Management of immunocompromised patients", "Evaluation of transplant recipients", "Suspected central nervous system infections", "Early reactivation detection"] Measurement technique Confirm with laboratory Codes LOINC: 7754-9 ICD-10: B10.89, B10.81 Clinical summary This test detects the presence of Human Herpesvirus 6 (HHV-6) DNA and RNA in various body fluids.
TEST-849 HHV‑7 DNA & RNA Detection Qualitative Test This test detects the presence of active Human Herpesvirus 7 (HHV‑7) DNA and RNA in a sample.	Hospital Extraction Only	24–36 Hours	650.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["HHV‑7 DNA", "HHV‑7 RNA"] Parameters [] Preparation ["No fasting required.", "No medication withholding required unless specifically instructed by your physician."] Indications ["Unexplained febrile syndromes", "Roseola-like exanthems", "Suspected viral reactivation in immunocompromised patients"] Measurement technique Confirm with laboratory Codes LOINC: 50199-8 ICD-10: B08.2, Z20.828, Z13.6 Clinical summary This test detects the presence of active Human Herpesvirus 7 (HHV‑7) DNA and RNA in a sample.
TEST-264 Hi-C Sequencing and Analysis Test This test evaluates the three-dimensional architecture of the genome by mapping long-range chromatin interactions.	Whole Blood (EDTA, ≥5 mL) or Extracted DNA (≥1 µg, A260/280 1.8–2.0)	10 weeks	25,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Long-range chromatin interactions", "Genome folding", "Enhancer-promoter loops", "Epigenetic changes"] Parameters [] Preparation ["No fasting or dietary restrictions required", "Common supplements and medications do not interfere"] Indications ["Oncology (tumour-specific enhancer-promoter loops)", "Rheumatology (autoimmune-related epigenetic changes)", "Anti-aging (biological age clocks)", "Investigation of structural variants"] Measurement technique Confirm with laboratory Codes LOINC: 101353-4 ICD-10: Z13.79 Clinical summary This test evaluates the three-dimensional architecture of the genome by mapping long-range chromatin interactions.
TEST-160 Hi-C Sequencing Data Analysis Test This test evaluates the three-dimensional organization of the genome by mapping long-range chromatin interactions.	Peripheral whole blood (5 mL EDTA) or extracted DNA (≥1 µg, ≥50 ng/µL)	4 weeks	7,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Long-range chromatin interactions", "Structural variants", "Enhancer-promoter rewiring", "Chromatin mis-folding", "Topologically associating domains"] Parameters [] Preparation ["No special preparation needed", "Standard whole-blood sample required", "Extracted DNA is also accepted"] Indications ["Investigation of suspected cancer predisposition", "Diagnosis of autoimmune disorders", "Evaluation of developmental conditions", "Identification of structural variants", "Understanding regulatory network alterations"] Measurement technique Confirm with laboratory Codes LOINC: 81344-5 ICD-10: Z01.89, Z13.79 Clinical summary This test evaluates the three-dimensional organization of the genome by mapping long-range chromatin interactions.
TEST-236 Hi‑C Sequencing Test This test evaluates the three-dimensional structure of the genome by mapping long-range chromatin interactions.	Whole blood (EDTA tubes) or extracted DNA	6 weeks	20,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Long-range chromatin interactions", "Structural variations", "Genome architecture"] Parameters [] Preparation ["No fasting required", "Avoid heparin collection tubes", "Discuss blood collection with physician if on anticoagulants or antiplatelet therapy"] Indications ["Advanced cancer research", "Chromosomal rearrangement studies", "Developmental biology research", "Identifying structural variants missed by conventional sequencing"] Measurement technique Confirm with laboratory Codes LOINC: 88834-1 ICD-10: Z13.79 Clinical summary This test evaluates the three-dimensional structure of the genome by mapping long-range chromatin interactions.
TEST-1512 HIV-1 Genotyping & Drug Resistance Test (Reverse Transcriptase PCR & DNA Sequencing) This test identifies HIV-1 mutations associated with drug resistance in the protease, reverse transcriptase, and integrase genes.	Peripheral whole blood (EDTA plasma)	15th or 30th of each month (batch-processed)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["HIV-1 protease gene mutations", "HIV-1 reverse transcriptase gene mutations", "HIV-1 integrase gene mutations", "Drug susceptibility scores (Stanford HIVdb)"] Parameters [] Preparation [] Indications ["Virologic failure on current ART", "Before initiation of ART", "Monitoring treatment response"] Measurement technique Confirm with laboratory Codes LOINC: 37003-9 ICD-10: B20 Clinical summary This test identifies HIV-1 mutations associated with drug resistance in the protease, reverse transcriptase, and integrase genes.
TEST-6300 HJV Gene Hemochromatosis Type 2A Genetic Test This genetic test analyzes the HJV gene to detect mutations associated with juvenile hemochromatosis (Type 2A).	Whole Blood / Extracted DNA / FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the HJV gene"] Parameters [] Preparation ["No fasting required", "Pre-test genetic counseling session mandatory"] Indications ["Suspected juvenile hemochromatosis", "Family history of HJV-related hemochromatosis", "Elevated iron studies (ferritin, transferrin saturation)"] Measurement technique Confirm with laboratory Codes LOINC: 82662-9 ICD-10: E83.11 Clinical summary This genetic test analyzes the HJV gene to detect mutations associated with juvenile hemochromatosis (Type 2A).
TEST-1505 HLA-B1502 Genotyping (Carbamazepine) Test This diagnostic test evaluates the presence or absence of the HLA-B1502 allele, a genetic variant linked to severe adverse reactions to carbamazepine.	Peripheral Whole Blood (EDTA Tube)	10 Working Days	700.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Presence of HLA-B1502 allele", "Genetic predisposition to carbamazepine-induced SCARs"] Parameters [{"name": "HLA-B1502 Allele", "reference_range": "Negative / Positive"}] Preparation ["No specific fasting required", "No medication adjustments needed"] Indications ["Pre-therapy screening for carbamazepine", "Patients of Asian descent initiating carbamazepine", "Risk assessment for SJS/TEN"] Measurement technique Confirm with laboratory Codes LOINC: 79529-5 ICD-10: Z13.89 Clinical summary This diagnostic test evaluates the presence or absence of the HLA-B*1502 allele, a genetic variant linked to severe adverse reactions to carbamazepine.
TEST-1498 HLA-B57:01 Genotyping (Abacavir Hypersensitivity) Test This test detects the presence or absence of the HLA-B57:01 allele in a patient's DNA.	Peripheral Whole Blood	7 Working Days	750.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Presence of HLA-B57:01 allele"] Parameters [] Preparation ["No special preparation required", "Inform your physician of any current medications", "Do not discontinue prescribed therapy without medical consultation"] Indications ["Mandatory screening before initiating abacavir therapy in the UAE", "Patients prescribed abacavir"] Measurement technique Confirm with laboratory Codes LOINC: 90839-9 ICD-10: Z13.89 Clinical summary This test detects the presence or absence of the HLA-B57:01 allele in a patient's DNA.
TEST-1537 HLA-B27 Qualitative PCR Test This test detects the presence or absence of the HLA-B27 gene variant in a patient's DNA.	Peripheral whole blood	10–12 working days	700.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Presence of HLA-B27 gene variant"] Parameters [] Preparation ["No special preparation, fasting, or medication adjustment is needed."] Indications ["Suspected ankylosing spondylitis", "Suspected reactive arthritis", "Suspected psoriatic arthritis", "Suspected uveitis", "Family history of HLA-B27 associated diseases"] Measurement technique Confirm with laboratory Codes LOINC: 37897-1 ICD-10: Z01.89 Clinical summary This test detects the presence or absence of the HLA-B27 gene variant in a patient's DNA.
TEST-6320 HNF1A Gene (MODY3) Genetic Test This test identifies mutations within the HNF1A gene, confirming a diagnosis of MODY3.	Peripheral Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["HNF1A gene coding region variants", "Presence of pathogenic mutations in HNF1A"] Parameters [] Preparation ["Mandatory pre-test genetic counselling session required", "No specific fasting required for blood draw"] Indications ["Diagnosis of suspected MODY3", "Differentiation from other forms of diabetes", "Guidance for personalised treatment (e.g., sulfonylurea sensitivity)"] Measurement technique Confirm with laboratory Codes LOINC: 21652-0 ICD-10: E11.8 Clinical summary This test identifies mutations within the HNF1A gene, confirming a diagnosis of MODY3.
TEST-6025 HNF1A Gene MODY Type 3 Genetic Test This test identifies pathogenic variants in the HNF1A gene, confirming MODY type 3, a monogenic form of diabetes.	Whole blood (venous) or FTA card (finger-prick)	3–4 weeks (optional STAT reporting)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic HNF1A gene variants", "Copy number analysis of HNF1A gene"] Parameters [] Preparation ["No specific fasting required", "No medication adjustments needed before testing"] Indications ["Diagnosis of monogenic diabetes", "Family screening for MODY", "Guiding sulfonylurea therapy"] Measurement technique Confirm with laboratory Codes LOINC: 92807-7 ICD-10: E13.9 Clinical summary This test identifies pathogenic variants in the HNF1A gene, confirming MODY type 3, a monogenic form of diabetes.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Molecular Diagnostics tests in Dubai & UAE

Molecular Diagnostics test prices

Molecular Diagnostics: overview

Use the test details as a conversation starter

Related Molecular Diagnostics categories